Personalized Therapy Growth Driven by Clinical Diagnostics
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Personalized Therapy Growth Driven by Clinical Diagnostics
-
Narrated by:
-
By:
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent industry news and how clinical diagnostics are powering more personalized care. Together, they explore:
- Point-of-care testing in outbreak response (00:29): Hear about the potential and limitations of point-of-care testing during disease outbreaks.
- A rare type of Lyme disease (02:46): Learn about the spread of the second known pathogen to cause Lyme disease in the U.S.
- The evolution of AI (04:50): Dr. Morice shares insights from a recent conference, highlighting the shift from discussing artificial intelligence’s potential to scaling real-world clinical applications.
- Personalized medicine and diagnostics (06:07): Discover how clinical diagnostics are driving personalized medicine and how data will shape its future.
Resources
- Four ways diagnostics are driving more personalized care
- "Answers From the Lab" podcast: Advancing Precision Medicine Through Therapeutic Tests
- "Answers From the Lab" podcast: Risks Increase as Ticks, Mosquitoes, and Similar Vectors Spread
- Therapeutics testing: Discover the differences
adbl_web_anon_alc_button_suppression_t1
No reviews yet